← Eichor
Study identifier: NCT06668623 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy

Condition: Diabetic Neuropathy  ·  Sponsor: TC Erciyes University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The study is planned to be conducted in a mixed research design with quantitative and qualitative types. The quantitative phase of the study was planned as a single-blind, randomized controlled study with Reiki group, Sham Reiki group and control group designs in order to examine the effect of second-level (remote application) Reiki applied to patients with diabetic neuropathy for 20 minutes a day for four days on pain intensity, neuropathic pain intensity (DN4 Questionnaire) total scores and sleep quality. The qualitative study will be conducted with 4 people from the Reiki and Sham Reiki groups, a total of 8 patients, one week after the application, using the individual in-depth interview method and a semi-structured questionnaire.

This description comes directly from the study's public registry record.

Talk to the study team

Fatma G. BURKEV, PhD student  ·  +90 0352 315 77 00  ·  fatmaburkev@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kayseri City HospitalKayseri, Kocasinan, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06668623